Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 8, 2014
Effectiveness of an algorithm-based approach to the utilization of plerixafor in patients undergoing chemotherapy-based stem cell mobilizationEric Chow, Kamakshi V Rao, William A Wood, et al.
Open Forum Infectious Diseases|January 16, 2025
The Prevalence of Multidrug Resistance in Enterobacterales Is Higher in Patients Undergoing Hematopoietic Stem Cell TransplantationTessa M Andermann, Dylan Brown, Thomas Holowka, et al.
Blood Advances|August 18, 2018
Computational modeling and confirmation of leukemia-associated minor histocompatibility antigensJefferson L Lansford, Udara Dharmasiri, Shengjie Chai, et al.
Chemical Communications (Cambridge, England)|January 24, 2015
Enzymatic cleavage of uracil-containing single-stranded DNA linkers for the efficient release of affinity-selected circulating tumor cellsSoumya V Nair, Małgorzata A Witek, Joshua M Jackson, et al.
Clinical and Experimental Immunology|November 11, 2023
CD3 downregulation identifies high-avidity human CD8 T cellsGenevieve T Clutton, Ann Marie K Weideman, Melissa A Mischell, et al.
Transplantation and Cellular Therapy|June 18, 2026
Evaluating day +90 donor chimerism as a prognostic marker of clinical outcomes among allogeneic hematopoietic cell transplant recipients who received myeloablative conditioningSara Jubas, Kieran Collins, Kendall Obara, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 13, 2012
The role of antigen cross-presentation from leukemia blasts on immunity to the leukemia-associated antigen PR1Gheath Alatrash, Yoko Ono, Anna Sergeeva, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 24, 2018
Evaluation of a Test Dose Strategy for Pharmacokinetically-Guided Busulfan Dosing for Hematopoietic Stem Cell TransplantationJessica M Davis, Anastasia Ivanova, Yunro Chung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2012
A novel HLA-A*0201 restricted peptide derived from cathepsin G is an effective immunotherapeutic target in acute myeloid leukemiaMao Zhang, Pariya Sukhumalchandra, Atim A Enyenihi, et al.
The Journal of Clinical Investigation|April 5, 2017
Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host diseaseDanny W Bruce, Heather E Stefanski, Benjamin G Vincent, et al.
Pageof 5